Pages that link to "Q56115291"
Jump to navigation
Jump to search
The following pages link to Psoriasis (Q56115291):
Displaying 50 items.
- Recent advances in understanding psoriasis (Q26751223) (← links)
- The German National Program on Psoriasis Health Care 2005-2015: results and experiences (Q26751448) (← links)
- Cutaneous manifestations of hepatitis C in the era of new antiviral agents (Q26773669) (← links)
- IL-18 and Cutaneous Inflammatory Diseases (Q26774403) (← links)
- An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature (Q26777515) (← links)
- T Helper Cell Subsets in Clinical Manifestations of Psoriasis (Q28069848) (← links)
- Management of psoriasis patients with hepatitis B or hepatitis C virus infection (Q28078157) (← links)
- Pediatric Psoriasis (Q30234370) (← links)
- A systematic review of worldwide epidemiology of psoriasis (Q30248242) (← links)
- Co-morbidity in psoriasis: mechanisms and implications for treatment (Q30248952) (← links)
- Epigenome-wide association data implicates DNA methylation-mediated genetic risk in psoriasis. (Q31149307) (← links)
- CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin (Q33390838) (← links)
- Tristetraprolin expression by keratinocytes controls local and systemic inflammation. (Q33752343) (← links)
- The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci (Q33803222) (← links)
- Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis (Q33826257) (← links)
- Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation (Q33897776) (← links)
- IL-27-induced modulation of autoimmunity and its therapeutic potential (Q34488727) (← links)
- Deranged iron status in psoriasis: the impact of low body mass. (Q36349371) (← links)
- Update on psoriasis immunopathogenesis and targeted immunotherapy. (Q36445919) (← links)
- A Preliminary, Open Label, Single-arm Study of Calcipotriene/Betamethasone Topical Suspension as a Supplement to Non-biologic Systemic Therapy for Psoriasis (Q36982667) (← links)
- RAC1 activation drives pathologic interactions between the epidermis and immune cells (Q37042288) (← links)
- Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis (Q37306962) (← links)
- Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study. (Q37378359) (← links)
- Association of C-Reactive Protein (rs1205) Gene Polymorphism with Susceptibility to Psoriasis in South Indian Tamils. (Q37435438) (← links)
- Vascular Features of Nail Psoriasis Using Dynamic Optical Coherence Tomography. (Q37604778) (← links)
- Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action (Q37690626) (← links)
- Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference. (Q37690746) (← links)
- Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry (Q38372071) (← links)
- Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study (Q38630637) (← links)
- TRB3 is elevated in psoriasis vulgaris lesions and mediates HaCaT cells proliferation in vitro (Q38633290) (← links)
- Adalimumab: A Review in Chronic Plaque Psoriasis (Q38639495) (← links)
- Secukinumab (AIN-457) for the treatment of Psoriasis (Q38662868) (← links)
- Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis (Q38673099) (← links)
- Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation (Q38673434) (← links)
- A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast (Q38675867) (← links)
- Psoriasis and migraine (Q38679385) (← links)
- The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis. (Q38707588) (← links)
- Emerging drugs for psoriatic arthritis (Q38710642) (← links)
- Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study (Q38723865) (← links)
- Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis (Q38725225) (← links)
- IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis (Q38751686) (← links)
- The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury (Q38758398) (← links)
- Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies (Q38780235) (← links)
- Tattooing and psoriasis: a case series and review of the literature (Q38790016) (← links)
- New therapies for psoriasis and psoriatic arthritis (Q38792080) (← links)
- The Inflammatory Response in Psoriasis: a Comprehensive Review (Q38792930) (← links)
- Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development (Q38794037) (← links)
- Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America (Q38800156) (← links)
- Prevalence of coronary artery calcification in Japanese patients with psoriasis: A close correlation with bilateral diagonal earlobe creases (Q38808623) (← links)
- Control of autoimmune inflammation by celastrol, a natural triterpenoid (Q38894091) (← links)